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Abstract
Purpose To identify personal, occupational and clinical factors associated with the lifting of restrictions on duties among 
Royal Air Force (RAF) personnel who have returned to work after surviving primary cancer treatment. Methods A retrospec-
tive cohort of 205 RAF personnel aged 18–58 with cancer diagnosed between 2001 and 2011 was followed-up until May 
2012. Personal, occupational, and clinical information was extracted from occupational health and primary care records. 
Predictors of the lifting of (a) employment restrictions on UK duties at 18 months after diagnosis and (b) the lifting of all 
deployment restrictions at the end of the study were analysed using logistic and Cox regression models. Results At 18 months, 
62% of the cancer survivors had restrictions on their UK duties lifted. The positive independent predictors of unrestricted UK 
duties are testicular cancer (OR 5.34; 95% CI 1.21–23.6) and no treatment being required (16.8; 1.11–255.2). The lifting of 
all employment restrictions and return to full deployability was achieved by 41% of the participants (median time 2.1 years), 
with testicular cancer (HR 2.69; 95% CI 1.38–5.26) and age at diagnosis (1.05; 1.01–1.09) being the positive independent 
predictors of faster lifting of all restrictions. Conclusion Diagnostic group, prognosis and type of treatment are not the only 
predictor of employment outcome after cancer. Patient-centred factors such as smoking, age, fatigue, job status, job type 
and length of employment are also important predictors of return to pre-morbid job function in cancer survivors in the RAF.
Keywords Workability · Job function · Cancer survivor · Predictor · Military
Introduction
There are currently over 750,000 people of working age in 
the UK living with a cancer diagnosis, with 120,000 new 
cases reported each year [1]. These substantial numbers, 
along with significant increases in survival due to early 
detection and treatment, have resulted in increasing numbers 
of cancer survivors returning to work [2, 3].
Previous studies have reported the predictors of return to 
work (RTW) in cancer survivors [4, 5], but the predictors of 
return to pre-morbid levels of job function after RTW, which 
are important in understanding the true impact of cancer on 
work [6], have not been investigated in detail. Several studies 
have included questions on occupational role after RTW, but 
they have only reported crude prevalence of self-reported 
difficulties; reduced working hours and changes in occupa-
tion [7, 8]; and difficulty with physical and cognitive tasks 
[9, 10]. A review in 2009 identified 19 studies on the cor-
relates of job function in cancer survivors; however, all these 
studies relied on self-reported measures of job function, 
and often did not distinguish between the working and non-
working population [11]. The study by Ohguri et al. in Japan 
was one of the few studies which investigated influences on 
return to full job function after cancer patients RTW [12]. In 
Ohguri et al’s retrospective study, 134 cancer survivors in a 
single manufacturing company were assessed by an occupa-
tional physician, 59% required adjustments to their original 
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jobs, the majority being prohibition of shift work and over-
time work. To our knowledge there is no information on the 
moderators of rehabilitation to pre-morbid job duties after 
RTW in a military population. Here we report the findings 
of an investigation of a cohort of cancer survivors in the 
Royal Air Force (RAF), of whom detailed information on 
job restrictions up to 10 years after diagnosis is available. 
The RAF employed 41,170 personnel at the conclusion 
of this study, with the majority being employed in flying, 
engineering and technical environments. The majority of 
roles entail safety-critical components and all personnel are 
required to safely handle a personal weapon.
Methods
Details of the identification of cancer survivors in the RAF 
have been reported elsewhere [5]. In sum, we included all 
RAF personnel (aged 18–58 years) who survived primary 
treatment for cancer between January 2001 and Decem-
ber 2011, identified through records from the RAF Medi-
cal Board (RAFMB), which reviewed all cancer cases at 
approximately 18 months post-diagnosis. We excluded those 
who were on terminal leave when diagnosed and those who 
had non-metastatic cancers (e.g. basal cell carcinoma). The 
RAF Experimental Medicine Scientific Advisory Commit-
tee and the Ministry of Defence Research Ethics Committee 
approved the study protocol. Informed, written consent was 
obtained from all participants.
Due to the safety-critical nature of employment in the 
RAF, all personnel with a diagnosis of cancer must be medi-
cally certified by an occupational physician prior to a return 
to their full job role. All personnel are awarded a codified 
medical employment job role (Medical Employment Stand-
ard; MES), which is based on functional status and employ-
ability and includes consideration of the work environment, 
job demands, individual function (such as cognitive abili-
ties), deployability and requirement for medical follow-up. 
The broad categories of job function comprise: L1/2—no 
restrictions; L3—minor restrictions where the individual 
can undertake all their UK duties, but not the more arduous 
general military duties (i.e. unfit for duties outside the UK, 
unfit for weapon handling and unfit deployments without 
access to appropriate medical care); and L4—major restric-
tions where the individual is unable to fully undertake their 
UK duties or general military duties (i.e. if there is a risk of 
sudden incapacity due to cancer metastases aircraft techni-
cians may be made unfit to work in confined spaces, RAF 
drivers may be unfit driving military vehicles and aircrew 
may be unfit for flying duties).
We searched all medical records for the employment 
restrictions awarded at 18 months, and any subsequent 
changes in restrictions up until May 2012 and ascertained 
the time to the lifting of all employment restrictions after 
cancer survivors in the RAF had returned to work.
We examined the health records of participants to obtain 
age at diagnosis, gender, marital status (single, married/in 
civil partnership), body mass index (BMI, which was derived 
from height and weight pre-diagnosis), smoking status (cur-
rent smoker or not), weekly alcohol intake (< or > 10 units), 
rank (in five groups), three trade group (engineering, air-
crew, and ground crew, which included drivers, chefs, com-
munication technicians and firefighters), years left to serve 
at diagnosis (cut-off at median: < 5, ≥ 5 years), site of cancer 
(melanoma, haematological, testicular, breast, gastrointes-
tinal, urinary tract, head and neck, intra-cranial, connective 
tissue, and other), and treatment modality (none, surgery, 
radiotherapy, chemotherapy or combinations of radiotherapy 
and chemotherapy). Prognosis was classified as “good” if 
5-year survival ≥ 70%, and “poor” if < 70%, according to the 
detailed secondary care correspondence on staging available 
for all participants. The presence of fatigue symptoms at the 
post 6-months diagnosis stage was defined as either a men-
tion in the RAFMB medical review, or if the participants 
complained of it twice or more, more than 1 week apart in 
their primary care consultations. The Charlson co-morbidity 
index [13] was derived based on the presence of co-morbid 
conditions recorded in the report submitted to RAFMB, and 
was dichotomised into 0 and ≥ 1.
The primary outcome was lifting of restrictions on UK 
duties at 18 months (as decided by the RAFMB). Univari-
ate analysis was performed using t test, Chi square test or 
Fisher exact test where appropriate. We only included those 
anatomical categories that yielded a P value of ≤ 0.1 with 
logistic regression (testicular, melanoma, gastrointestinal, 
and connective tissue), with the rest being grouped ‘‘other’’ 
as a reference group. We entered all potential predictor vari-
ables aforementioned using forward selection (retained when 
P ≤ 0.1) in a multivariate logistic regression analysis, from 
which we obtained odds ratios (ORs) and the corresponding 
95% confidence intervals (CIs). The analysis for the time to 
the lifting of all employment restrictions was ascertained 
by means of a Cox proportional hazards regression model 
with forward selection (retained when P ≤ 0.1). We report 
the hazards ratios (HRs) of faster lifting of all restrictions 
and the associated 95% CIs. All statistical analyses were 
performed using STATA version 13 [14].
Results
We identified 219 cancer survivors from the database of 
which 14 were excluded due to terminal leave from the RAF 
when diagnosed or because they had cancer which does not 
typically metastasise. About half of the included 205 partici-
pants were diagnosed before 40 years, with testicular (19%), 
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haematological (17%) and melanoma (16%) being the most 
common cancers. Six participants did not require any treat-
ment as per recommendations by the consultants (five hav-
ing early stage chronic lymphocytic leukaemia, or clinically 
quiescent cutaneous lymphoma/follicular lymphoma and 
one having stage one adenocarcinoma of prostate, with low 
prostate specific antigen level where only active monitor-
ing was advised). The RAFMB (at around 18 months after 
diagnosis) agreed to 128 (62%) cancer survivors having their 
restrictions on their work duties lifted. While those who 
had restrictions on their UK duties lifted had similar demo-
graphic characteristics compared to those who did not, the 
former group had more benign cancers that required surgery 
only; had much better prognosis; and were also less likely 
to experience fatigue at 6 months post-diagnosis (Table 1). 
Logistic regression analysis identified that the only factors 
to favour the lifting of UK restrictions were testicular cancer 
(adjusted OR 5.34; 95% CI 1.21–23.6) and when no treat-
ment was required (16.8; 1.11–255.2). On the other hand, 
smoking at diagnosis (0.31; 0.11–0.89), having ≥ 5 years left 
to serve in the RAF (0.30; 0.11–0.82), connective tissue can-
cer (0.03; 0.002–0.43), having fatigue symptoms at 6 months 
after diagnosis (0.16; 0.05–0.56), and Charlson comorbidity 
index being ≥ 1 (0.14; 0.03–0.63) were independent negative 
predictors of the lifting of UK restrictions (Table 2).
By the end of the follow-up period, 83 (41%) of the cancer 
survivors had all employment restrictions lifted, 53 (26%) 
had overseas/deployment/weapon restrictions (L3) only 
and 34 (17%) still had significant UK restrictions on their 
work (L4). The median time to the lifting of all restrictions 
was 2.1 years (range 0.9–6.2 years). Potential predictors of 
the faster (counted in days) lifting of all restrictions were 
entered in the Cox regression with a forward selection, with 
the final model presented in Table 3. Older age at diagnosis 
(adjusted HR 1.05; 95% CI 1.01–1.09) and having testicular 
cancer (2.69; 1.38–5.26) were significant predictors of faster 
lifting of restrictions, whilst higher rank (0.13; 0.03–0.52) 
or having poor prognosis (0.49; 0.25–0.93) were significant 
predictors of slower lifting of restrictions.
Discussion
We have previously reported on the predictors of RTW after 
sickness absence in cancer survivors in the RAF [5]; how-
ever, the success of occupational rehabilitation after RTW 
in this group (who work in a highly technical and safety-
critical environment) was unknown. In this study of cancer 
survivors after they returned to work in the RAF, 62% had 
restrictions on their UK duties lifted by 18 months after 
diagnosis and 41% had all employment restrictions lifted 
after a median of about 2 years from diagnosis. To our 
knowledge, this is the first study in which the predictors of 
return to full pre-morbid job role following return to work 
after primary treatment for cancer have been analysed in a 
military population.
Of all the diagnoses, only testicular cancer was found 
to be significantly associated with the lifting of specialist 
restrictions and the faster lifting of all restrictions, although 
a diagnosis of melanoma was only just short of statistical 
significance. Both testicular cancer and low Breslow-thick-
ness malignant melanoma have a very good prognosis and 
high 10-year survival rates [15] (of the 33 melanomas in this 
study, only 2 had a poorer prognosis, with > 4 mm Breslow 
thicknesses). Therefore, it is not surprising that patients with 
such diagnoses were more likely to have employment restric-
tions lifted quickly. In addition, we found that the absence 
of treatment was associated with early lifting of specialist 
employment restrictions and (although not statistically sig-
nificant) we found a trend towards increased employment 
restrictions following surgery only, which was less than 
radiotherapy only, which in turn was less than chemotherapy 
only; with combined radio/chemotherapy attracting the most 
restrictions. The negative predictors of the lifting of UK 
employment restrictions were smoking at diagnosis, work-
ing as aircrew, having ≥ 5 years left to serve in the RAF, 
presence of fatigue symptoms at 6 months and comorbidi-
ties. However, older age at diagnosis, higher rank and poor 
prognosis were more important barriers to the eventual 
lifting of all employment restrictions. Knowledge of such 
predictors may help patients and health-care professionals 
in decision-making and the management of expectations at 
an early stage after diagnosis. Having longer left to serve in 
the RAF may be a negative predictor because those near-
ing their end-of-contract date could be more motivated to 
return to unrestricted employment, as this is required for 
contract extension. Higher rank may be a positive predictor 
due to the increased control of job adjustments and ability 
to delegate physical tasks that come with such status; and 
older age due to the ‘healthy worker’ effect (this is likely to 
be significant in an organisation that requires no medical 
employment restrictions to extend contracts).
Early employability reviews after diagnosis seem to be 
more influenced by personal factors (such as smoking and 
co-morbidity), possible treatment-related factors (fatigue) 
and individuals in safety-critical work roles (aircrew). 
Whereas later reviews seem to be more affected by poor 
prognosis, high rank and older age. A possible reason for 
those of higher rank having all employment restrictions 
lifted more slowly may be a consequence of the UK Armed 
Forces’ career structure: higher ranks are more likely to have 
had their contract extended to retirement age before diag-
nosis and may therefore be less motivated to return to the 
full function that such extensions require. The independent 
effect of age may be related to the decreasing adaptability 
inherent in senescence.
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To our knowledge there is only one study in the litera-
ture that had direct access to sufficient information in order 
to analyse employer-imposed restrictions on job role after 
cancer survivors’ RTW [12]. This Japanese study analysed 
the predictors of occupational physician imposed limita-
tions (no, mild and high) and found chemotherapy to be 
significantly correlated with the degree of work limitations. 
While in the current study participants undergoing chemo-
therapy were less likely to have employment restrictions 
lifted, the association did not reach statistical significance. 
However, in the Japanese study, confounders and co-vari-
ates, such as diagnosis and prognosis, were not adjusted for, 
Table 1  Characteristics of 205 
RAF cancer survivors All Return to full UK duties at 18 months
Yes No P
n (row %) 205 128 (62) 77 (38)
Mean age (SD), year 37.7 (9.5) 39.8 (10.6) NS
Male (%) 181 113 (89) 68 (89) NS
Single (%) 49 30 (24) 19 (26) NS
Mean body mass index (SD), kg/m2 26.4 (3.3) 27.1 (4.1) NS
Current smoker (%) 44 23 (20) 21 (30) NS
Mean alcohol intake per week (SD), unit 11.2 (9.5) 13.0 (9.6) NS
Rank (%)
 1 (lowest) 63 38 (30) 25 (32)
 2 61 38 (30) 23 (30)
 3 40 31 (24) 9 (12)
 4 14 8 (6) 6 (8)
 5 (highest) 27 13 (10) 14 (18) NS
Trade group (%)
 Engineering 61 40 (31) 21 (27)
 Aircrew 43 20 (16) 23 (30)
 Other 101 68 (53) 33 (43) NS
Years left to serve (%)
 <5 90 48 (63) 42 (55)
 ≥5 115 80 (38) 35 (46) < 0.05
Cancer site (%)
 Melanoma 33 30 (23) 3 (4)
 Gastrointestinal 27 10 (8) 17 (22)
 Breast 14 9 (7) 5 (6)
 Testicular 39 33 (26) 6 (8)
 Haematological 34 22 (17) 12 (16)
 Head and neck 12 5 (4) 7 (9)
 Urinary tract 19 13 (10) 6 (8)
 Intra-cranial 11 0 (0) 11 (14)
 Connective tissue 7 2 (2) 5 (6)
 Other 9 4 (3) 5 (6) < 0.001
Treatment modality (%)
 None 6 5 (4) 1 (1)
 Surgery 91 69 (54) 22 (29)
 Radiotherapy 21 10 (8) 11 (14)
 Chemotherapy 55 29 (23) 26 (34)
 Radiotherapy and chemotherapy 32 15 (12) 17 (22) < 0.01
Poor prognosis (%) 86 39 (31) 47 (63) < 0.001
Charlson comorbitidy index (%)
 0 191 121 (95) 70 (91)
 ≥1 14 7 (5) 7 (9) NS
Fatigue symptoms at 6 months (%) 44 18 (14) 26 (34) < 0.01
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Table 2  Predictors of removal 
of specialist employment 
restrictions at 18 months
Crude OR 95% CI Adjusted OR 95% CI
Male 0.95 0.38–2.38 1.97 0.39–10.0
Body mass index, kg/m2 0.95 0.87–1.03 0.97 0.85–1.09
Current smoker 0.60 0.30–1.18 0.31 0.11–0.89
Alcohol intake per week, unit 0.98 0.95–1.01 0.99 0.94–1.03
Trade group
 Engineering 1.00 1.00
 Aircrew 0.46 0.21–1.01 0.03 0.006–0.18
 Other 1.08 0.55–2.12 0.66 0.22–1.94
Left to serve ≥ 5 years 0.50 0.28–0.89 0.30 0.11–0.82
Cancer site
 Melanoma 8.68 2.48–30.3 4.07 0.65–25.6
 Gastrointestinal 0.51 0.21–1.23 0.97 0.26–3.58
 Testicular 4.77 1.84–12.4 5.34 1.21–23.6
 Connective tissue 0.35 0.06–1.88 0.03 0.002–0.43
 Other 1.00 1.00
Treatment modality
 None 1.59 0.18–14.4 16.8 1.11–255.2
 Surgery 1.00 1.00
 Radiotherapy 0.29 0.11–0.77 0.69 0.16–2.96
 Chemotherapy 0.36 0.17–0.73 0.57 0.16–2.10
 Radiotherapy and chemotherapy 0.28 0.12–0.65 0.30 0.07–1.24
Poor prognosis 0.27 0.15–0.49 0.51 0.18–1.42
Fatigue symptoms at 6 months 0.32 0.16–0.64 0.16 0.05–0.56
Charlson comorbidity index ≥ 1 0.58 0.19–1.72 0.14 0.03–0.63
Table 3  Predictors of removal 
of all employment restrictions Crude HR 95% CI Adjusted HR 95% CI
Age at diagnosis, years 1.01 0.98–1.03 1.05 1.01–1.09
Rank
 1 (lowest) 1.00 1.00
 2 1.17 0.68–2.01 0.98 0.50–1.92
 3 1.14 0.64–2.01 0.78 0.36–1.66
 4 2.64 1.14–6.10 1.57 0.50–4.94
 5 (highest) 0.33 0.10–1.09 0.13 0.03–0.52
Cancer site
 Melanoma 1.58 0.89–2.80 1.14 0.56–2.31
 Gastrointestinal 0.90 0.37–2.16 1.08 0.40–2.92
 Testicular 2.41 1.42–4.10 2.69 1.38–5.26
 Connective tissue 1.62 0.38–6.81 1.17 0.25–5.44
 Other 1.00 1.00
Treatment modality
 None 1.60 0.57–4.46 3.24 0.97–10.8
 Surgery 1.00 1.00
 Radiotherapy 0.92 0.45–1.89 1.27 0.54–2.98
 Chemotherapy 0.56 0.32–0.99 0.56 0.28–1.10
 Radiotherapy and chemotherapy 0.40 0.19–0.85 0.60 0.25–1.43
Poor prognosis 0.43 0.26–0.72 0.49 0.25–0.93
Fatigue at 6 months 0.64 0.33–1.24 0.76 0.35–1.65
 Journal of Occupational Rehabilitation
1 3
with only the effects of age, treatment and pre-diagnosis 
shift/production-line work being analysed; therefore, direct 
comparisons with the current study are difficult.
The main strength of our study is the complete capture 
of cancer survivors in the RAF during the study period due 
to the requirement for a medical board prior to leaving the 
RAF. This helps minimise selection bias, which is otherwise 
common in population-based studies, and the loss-to-follow-
up bias that affects many cohort studies. Another advantage 
of the study is that the data were obtained from integrated 
records (primary care and occupational health) rather than 
self-reported data as in the previously mentioned study [12].
The study is, however, limited by a relatively small sam-
ple size, which is a result of the RAF’s policy to keep only 
6 years’ worth of local occupational records. Consequently, 
we were unable to recruit cancer survivors prior to 2001. 
In addition, wide confidence intervals were apparent in a 
number of risk estimates in certain subgroups due to small 
numbers. Interpretation of the findings should also be under-
taken with caution as this study of a military population 
may not be representative of employed cancer survivors in 
general; the study may be subject to healthy worker effects 
as those employed in the Armed Forces are selected in and 
out according to their past medical history and physical resil-
ience. Other limitations include the single rater (and there-
fore also the lack of tests for inter-rater reliability) and the 
use of study-specific instruments which could create issues 
with the reliability of more subjective outcomes, such as 
post-treatment symptoms and co-morbidity.
In conclusion, return to pre-morbid job function after 
return to work in cancer patients in the RAF can be predicted 
by a number of personal, occupational and clinical factors. 
Whilst the overall rates of the lifting of employment restric-
tions after return to work for cancer patients in the RAF are 
encouraging, there is a continuing need to identify survivors 
with vocational rehabilitation needs at an early stage in order 
to provide optimal workplace interventions and adjustments. 
The findings of this study may inform targeted interven-
tions designed to facilitate the rehabilitation process in the 
RAF and potentially other military institutions, and therefore 
reduce unnecessary work restrictions. The overall aim of 
vocational rehabilitation after cancer should be the return 
of the individual to a full job role and a fulfilling career, not 
just return to work.
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